has been cited by the following article(s):
[1]
|
In silico Prediction on the PI3K/AKT/mTOR Pathway of the Antiproliferative Effect of O. joconostle in Breast Cancer Models
Cancer Informatics,
2022
DOI:10.1177/11769351221087028
|
|
|
[2]
|
Telmisartan inhibits NSCLC A549 cell proliferation and migration by regulating the PI3K/AKT signaling pathway
Oncology Letters,
2018
DOI:10.3892/ol.2018.8002
|
|
|